The methylation level of the CTHRC1 promoter in GBM was lower than that in LGG, suggesting that abnormal methylation of DNA promoter may be an important factor for the high expression of CTHRC1 mRNA in glioma (Fig. 5e). The gene discussed is CTHRC1; the disease is central nervous system cancer.